NPS PHARMACEUTICALS INC Net Cash Provided by (Used in) Financing Activities, Continuing Operations
NPS PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Financing Activities, Continuing Operations of $8.43 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivitiesContinuingOperations · last filed 2015-02-18
- NPS PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for the quarter ending 2014-12-31 was $1.84M, a 48.86% decline year-over-year.
- NPS PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for the quarter ending 2013-12-31 was $3.60M.
- NPS PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for fiscal 2014 was $8.43M, a 92.20% decline from fiscal 2013.
- NPS PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for fiscal 2013 was $108.12M, a 4121.71% increase from fiscal 2012.
- NPS PHARMACEUTICALS INC net cash provided by (used in) financing activities, continuing operations for fiscal 2012 was $2.56M.
| Period end | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Financing Activities, Continuing Operations 12 month |
|---|---|---|---|
| 2014-12-31 | $1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $8.43M 10-K · filed 2015-02-18 | |
| 2014-09-30 | $6.59M 10-Q · filed 2014-11-10 | ||
| 2013-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $108.12M 10-K · filed 2015-02-18 | |
| 2013-09-30 | $104.52M 10-Q · filed 2014-11-10 | ||
| 2012-12-31 | $2.56M 10-K · filed 2015-02-18 |